An enzyme immunoassay for the quantification of plasma and intracellular lopinavir in HIV-infected patients

Journal of Immunological Methods

Volumn 295, Issue 1-2, 2004, Pages 37-48

  Azoulay, Stéphane ^a   Nevers, Marie Claire ^b   Créminon, Christophe ^b   Heripret, Laurence ^c   Garraffo, Rodolphe ^d   Durant, Jacques ^c   Dellamonica, Pierre ^c   Grassi, Jacques ^b   Guedj, Roger ^a   Duval, Danièle ^a  

^a Valrose   (France)

^b Institut National de la Recherche Agronomique   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d PASTEUR HOSPITAL   (France)

Author keywords

AIDS; ELISA; Intracellular protease inhibitor

Indexed keywords

ACETYLCHOLINESTERASE; ANTIGEN; CELL EXTRACT; KEYHOLE LIMPET HEMOCYANIN; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; POLYCLONAL ANTIBODY; RITONAVIR; TRACER; ANTIBODY; DIAGNOSTIC AGENT; PROTEINASE INHIBITOR; PYRIMIDINONE DERIVATIVE;

ARTICLE; BIOLOGICAL MONITORING; CASE REPORT; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; ENZYME IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLASTOID CELL LINE; MALE; MICROTITER PLATE ASSAY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; VALIDATION PROCESS; ADULT; CHEMISTRY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; METHODOLOGY; MONONUCLEAR CELL; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS; ORYCTOLAGUS CUNICULUS;

ADULT; ANTIBODIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PYRIMIDINONES; SENSITIVITY AND SPECIFICITY;

EID: 13844314388     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.08.016     Document Type: Article

References (30)

1. R.E. Aarnoutse, J.M. Schapiro, C.A. Boucher, Y.A. Hekster, and D.M. Burger Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs? Drugs 63 2003 741
2. F. Akeb, B. Ferrua, C. Creminon, C. Roptin, J. Grassi, M.C. Nevers, R. Guedj, R. Garraffo, and D. Duval Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA J. Immunol. Methods 263 2002 1
3. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307
4. M. Boffito, D.J. Back, P.G. Hoggard, A. Caci, S. Bonora, R. Raiteri, A. Sinicco, H.E. Reynolds, S. Khoo, and G. Di Perri Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoring AIDS 17 2003 1107
5. M. Boffito, P.G. Hoggard, W.E. Lindup, S. Bonora, A. Sinicco, S.H. Khoo, G. Di Perri, and D.J. Back Lopinavir protein binding in vivo through the 12-hour dosing interval Ther. Drug Monit. 26 2004 35
6. S. Bon, M. Huet, M. Lemonnier, F. Rieger, and J. Massoulie Molecular forms of Electrophorus acetylcholinesterase. Molecular weight and composition Eur. J. Biochem. 68 1976 523
7. P. Clevenbergh, R. Garraffo, and P. Dellamonica Impact of various antiretroviral drugs and their plasma concentrations on plasma lipids in heavily pretreated HIV-infected patients HIV Clin. Trials 4 2003 330
8. K.M. Crommentuyn, H. Rosing, L.G. Nan-Offeringa, M.J. Hillebrand, A.D. Huitema, and J.H. Beijnen Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry J. Mass Spectrom. 38 2003 157
9. J.A. Droste, C.P. Verweij-Van Wissen, and D.M. Burger Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography Ther. Drug Monit. 25 2003 393
10. J.J. Eron Jr. HIV-1 protease inhibitors Clin. Infect. Dis. 30 Suppl. 2 2000 S160
11. J. Faux, N. Venisse, J.C. Olivier, and S. Bouquet Rapid high-performance liquid chromatography determination of lopinavir, a Novel HIV-1 protease inhibitor, in human plasma Chromatographia 54 2001 469
12. V.A. Frerichs, R. DiFrancesco, and G.D. Morse Determination of protease inhibitors using liquid chromatography-tandem mass spectrometry J. Chromatogr. B, Anal. Technol. Biomed. Life Sci. 787 2003 393
13. P.A. Furman, J.A. Fyfe, M.H. St Clair, K. Weinhold, J.L. Rideout, G.A. Freeman, S.N. Lehrman, D.P. Bolognesi, S. Broder, and H. Mitsuya Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase Proc. Natl. Acad. Sci. U. S. A. 83 1986 8333
14. d.R. Gonzalez, F. Blanco, T. Garcia-Benayas, I. Jimenez-Nacher, J. Gonzalez-Lahoz, and V. Soriano Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir AIDS Patient Care STDs 17 2003 443
15. P.G. Hoggard, E.R. Meaden, P. Newton, I. Williams, J.F. Tjia, D. Aldam, D. Cornforth, D.J. Back, and S. Khoo Intracellular accumulation of lopinavir and ritonavir in HIV patients receiving Kaletra [Abstract 5.2] 3rd International Worshop on Clinical Pharmacology of HIV therapy, Washington 2002
16. K. Jones, P.G. Hoggard, S. Khoo, B. Maher, and D.J. Back Effect of alpha1-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro Br. J. Clin. Pharmacol. 51 2001 99
17. K. Jones, P.G. Hoggard, S.D. Sales, S. Khoo, R. Davey, and D.J. Back Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport AIDS 15 2001 675
18. K. Keil, V.A. Frerichs, R. DiFrancesco, and G. Morse Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma Ther. Drug Monit. 25 2003 340
19. S.H. Khoo, P.G. Hoggard, I. Williams, E.R. Meaden, P. Newton, E.G. Wilkins, A. Smith, J.F. Tjia, J. Lloyd, K. Jones, N. Beeching, P. Carey, B. Peters, and D.J. Back Intracellular accumulation of human immunodeficiency virus protease inhibitors Antimicrob. Agents Chemother. 46 2002 3228
20. G.N. Kumar, J. Dykstra, E.M. Roberts, V.K. Jayanti, D. Hickman, J. Uchic, Y. Yao, B. Surber, S. Thomas, and G.R. Granneman Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: a positive drug-drug interaction Drug Metab. Dispos. 27 1999 902
21. B. Ledergerber, M. Egger, M. Opravil, A. Telenti, B. Hirschel, M. Battegay, P. Vernazza, P. Sudre, M. Flepp, H. Furrer, P. Francioli, and R. Weber Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study Lancet 353 1999 863
22. P. Leibenguth, C. Le Guellec, J.M. Besnier, F. Bastides, M. Mace, M.L. Gaudet, E. Autret-Leca, and G. Paintaud Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection Ther. Drug Monit. 23 2001 679
23. W.J. Livingstone, M. Moore, D. Innes, J.E. Bell, and P. Simmonds Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group Lancet 348 1996 649
24. P.W. Mallon, J. Ray, and D.A. Cooper Effect of therapeutic drug monitoring on outcome in antiretroviral experienced HIV-infected individuals J. Clin. Virol. 26 2003 223
25. D. Nolan Metabolic complications associated with HIV protease inhibitor therapy Drugs 63 2003 2555
26. K.M. Rentsch Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry J. Chromatogr. B, Anal. Technol. Biomed. Life Sci. 788 2003 339
27. C.H. Soh, J.M. Oleske, M.T. Brady, S.A. Spector, W. Borkowsky, S.K. Burchett, M.D. Foca, E. Handelsman, E. Jimenez, W.M. Dankner, and M.D. Hughes Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents Lancet 362 2003 2045
28. M.E. Temple, K.I. Koranyi, and M.C. Nahata Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors Ann. Pharmacother. 37 2003 1214
29. J. Vaitukais Production of antisera with small doses of immunogen: multiple intradermal injections Methods in Enzymology 1981 Academic Press New York 46
30. T. Zhu, D. Muthui, S. Holte, D. Nickle, F. Feng, S. Brodie, Y. Hwangbo, J.I. Mullins, and L. Corey Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy J. Virol. 76 2002 707